Search

Author/Creator Letierce, Alexia

1. Alirocumab Add-on Therapy Versus Control in Individuals with Type 2 DM and ASCVD: ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN. (June 2018)

Authors:
Ray, Kausik K.; Del Prato, Stefano; Müller-Wieland, Dirk; Cariou, Bertrand; Colhoun, Helen M.; Henry, Robert R.; Tinahones, Francisco J.; Domenger, Catherine; Letierce, Alexia; Mandel, Jonas; Samuel, Rita; Bujas-Bobanovic, Maja; Leiter, Lawrence A.
Journal:
Atherosclerosis
Issue:
Volume 32(2018)
Page Start:
152
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Alirocumab vs usual lipid‐lowering care as add‐on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM‐DYSLIPIDEMIA randomized trial. Issue 6 (23rd March 2018)

Authors:
Ray, Kausik K.; Leiter, Lawrence A.; Müller‐Wieland, Dirk; Cariou, Bertrand; Colhoun, Helen M.; Henry, Robert R.; Tinahones, Francisco J.; Bujas‐Bobanovic, Maja; Domenger, Catherine; Letierce, Alexia; Samuel, Rita; Del Prato, Stefano
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 20:Issue 6(2018)
Page Start:
1479
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control. (September 2019)

Authors:
Vallejo-Vaz, Antonio J.; Ray, Kausik K.; Ginsberg, Henry N.; Davidson, Michael H.; Eckel, Robert H.; Lee, L. Veronica; Bessac, Laurence; Pordy, Robert; Letierce, Alexia; Cannon, Christopher P.
Journal:
Atherosclerosis
Issue:
Volume 288(2019)
Page Start:
85
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Effect of alirocumab on lipids and lipoproteins in individuals with metabolic syndrome without diabetes: Pooled data from 10 phase 3 trials. Issue 7 (25th March 2018)

Authors:
Henry, Robert R.; Müller‐Wieland, Dirk; Taub, Pam R.; Bujas‐Bobanovic, Maja; Louie, Michael J.; Letierce, Alexia; Ginsberg, Henry N.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 20:Issue 7(2018)
Page Start:
1632
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy and safety of alirocumab among individuals with diabetes mellitus and atherosclerotic cardiovascular disease in the ODYSSEY phase 3 trials. Issue 10 (2nd July 2018)

Authors:
Ganda, Om P.; Plutzky, Jorge; Sanganalmath, Santosh K.; Bujas‐Bobanovic, Maja; Koren, Andrew; Mandel, Jonas; Letierce, Alexia; Leiter, Lawrence A.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 20:Issue 10(2018)
Page Start:
2389
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy and safety of alirocumab in individuals with type 2 diabetes mellitus with or without mixed dyslipidaemia: Analysis of the ODYSSEY LONG TERM trial. (September 2018)

Authors:
Taskinen, Marja-Riitta; Del Prato, Stefano; Bujas-Bobanovic, Maja; Louie, Michael J.; Letierce, Alexia; Thompson, Desmond; Colhoun, Helen M.
Journal:
Atherosclerosis
Issue:
Volume 276(2018)
Page Start:
124
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Lower On‐Treatment Low‐Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials. Issue 18 (18th September 2018)

Authors:
Vallejo‐Vaz, Antonio J.; Ginsberg, Henry N.; Davidson, Michael H.; Eckel, Robert H.; Cannon, Christopher P.; Lee, L. Veronica; Bessac, Laurence; Pordy, Robert; Letierce, Alexia; Ray, Kausik K.
Journal:
Journal of the American Heart Association
Issue:
Volume 7:Issue 18(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study. (30th November 2020)

Authors:
Gaudet, Daniel; López-Sendón, José Luis; Averna, Maurizio; Bigot, Grégory; Banach, Maciej; Letierce, Alexia; Loy, Megan; Samuel, Rita; Manvelian, Garen; Batsu, Isabela; Henry, Patrick
Journal:
European journal of preventive cardiology
Issue:
Volume 28:Number 17(2021)
Page Start:
1864
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗